Rajiv Gandhi Cancer Institute and Research Centre,

New Delhi 110085

2 studies enrolling now · 3 studies all time

What they study most

Biliary Tract Cancer, Carcinoma, Squamous Cell, Neoplasm Metastasis, Palliative Care

Studies at this site

• JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC — Recruiting now
• Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer — Recruiting now
• A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone — Completed